Pharmalot By Ed Silverman Flawed trials supported half of recent approvals of cancer drugs in Europe, study says
Pharmalot By Ed Silverman European regulator recommends suspending numerous drugs over clinical trial problems
Pharmalot By Ed Silverman UK pharma trade group on Brexit: ‘There’s a potentially negative story here’
